Iryo is the first health record project which challenges this perception by tapping into the benefits of health data while ensuring data privacy.

Project stage


Detailed description

Iryo Network is a zero-knowledge health record storage platform, with an anonymous query interface. It uses blockchain permission controls for patient record access and tokens to incentivize end users consent enabling artificial intelligence (AI) research. 

The Iryo Network is a global repository of open EHR data. Since few people are prepared to provide their medical data to a “Google EHR”-type of capture and shameless reaping of all the medical data for commercial purposes, Iryo has decided to give up it’s access to plain data. Iryo perceives the medical data it holds as a “toxic asset”, because we believe that holding too much data in one place presents too large a liability risk.

A private decryption key remains on the patient’s device. Whenever someone wants to access patient data (a doctor or researcher, for example) the patient has to approve their access. This will be done by the patient clicking “yes’’ in their IryoEHR app. This gives a re-encryption key to the doctor’s public key. You can read more under the “Private key management section” to understand the details of this process and the application to the edge cases.


Iryo For Patients:

Institutional data ownership - Limited access to personal medical records.

Limited interoperability - Medical data is fragmented across a variety of incompatible systems.

Low-level security - Unauthorised parties can exploit personal medical data.

Iryo For Medical Staff:

Redundant medical systems - Medical staff are forced to enter similar data across multiple systems.

Outdated user platforms - Inefficient medical platforms increase wait times for treatment & disrupt medical workflows.

Limited IT support - Lack of IT support can lead to improper decision-making and decrease working efficiency.

Iryo For Researchers:

Limited research capabilities - Vendor-specific medical data hinders effective AI & big data analysis.

Narrow research scope - Fragmented data inhibits the ability to accurately target specific populations.

High costs - Ineffective data-gathering leads to an increase in research expenditure.

Iryo For Clinical Managers:

Single vendor lock-in - Hospitals & clinics are locked into vendor-specific IT ecosystems.

Ever-increasing medical costs - Legacy medical systems disrupt workflows and increase managerial overhead.

Centralized low-level security - Locally stored medical data is subject to cybersecurity attacks.


Iryo For Patients:

Self-sovereign data - Complete access & control over one’s own medical record.

Maximum interoperability - Interconnected systems allow for highly effective treatment options.

Unrivaled security - Health records stored in zero-knowledge & secured with modern cryptography.

Iryo For Medical Staff:

Single-entry system - Keeps data points consistent across all systems within the clinical workflow.

User friendly platform - Tailored and highly dynamic platforms enable efficiency within clinical workflows.

On-demand support - Effective IT support gives hospital staff the ability to better allocate their resources.

Iryo For Researchers:

Augmented research capabilities - Standardized medical data sets enable the utilization of big data, AI & machine learning.

Broad research scope - Targeted access to large pools of highly effective, anonymous medical data.

Predictive costs - Standardized data-gathering solutions enable a decrease in institutional expenditure.

Iryo For Clinical Managers:

Multi-vendor options - Iryo enables medical institutions to be flexible when choosing third-party providers.

Cost friendly solutions - Dynamic medical IT infrastructure solutions drive administrative costs down.

Decentralized zero-knowledge security - Highly encrypted medical data allows for the reallocation of medical IT resources.


Standardized Health Data
The Iryo Network is built on open EHR archetypes to ensure globally interoperable health data.

Zero-knowledge Data
Medical data is encrypted with zero-knowledge protocols to guarantee security & privacy.

Unified EHR
Unified medical records enable the efficient exchange of patient data between subjects of trust.

Open-source API
Iryo encourages developers to create their own solutions with the use of our open-source API.

Show details

Additional links

  • Token details

    • Token symbol ? Token symbol — a shorten token name. It is used during an ICO and after the coin listing at the cryptocurrency exchanges. : IRYO
    • Fundrasing target ? Fundraising target — the maximum amount of funds to be raised during an ICO. When it is reached, the developers stop selling the tokens because they do not need to raise more money for the project development. : 26,000,000 USD
    • Token type ? Token type — a platform for a startup launch that influences the stability of blockchain operation, the speed of transactions and the fees. :EOS ()
    • Soft cap ? Soft cap — the minimum amount of funds to be raised for the project development. Sometimes when the soft cap has not been reached, the money is returned to the participants. :8,000,000 USD
    • Role of token ? Role of Token — type of token depending on the opportunities it offers to its owner. Utility tokens give their owners a right to use the project services, security tokens are aimed at bringing profit, and currency tokens are a money substitute. :Utility token
    • Total supply ? Total supply — a total amount of tokens that will be released by the developers. :300,000,000 IRYO
    • Escrow agent ? Escrow agent — a qualified agent who has the right of signature in a multisig wallet. An escrow agent participates in an ICO, monitors the financial operations of the developers and confirms their fairness. :No
    • Tokens for sale ? Tokens for sale — the number of tokens offered to the participants of an ICO. :240,000,000 IRYO
    • Whitelist ? Whitelist — a list of participants, who get an opportunity to buy tokens. To be whitelisted, you need to register on time because the number of participants and the registration period are usually limited. :Whitelist Open(Start Mar 25, 2018)
    • Additional emission ? Additional emission — an additional release of tokens. It can be done once after the crowd sale or on an ongoing basis. In the projects with a limited emission there is no additional emission. :No
    • Exchange listing ? Exchange listing — an assumed date when the token will be listed at a cryptocurrency exchange. The developers usually indicate it in a roadmap and a white paper. :NA
    • Accepting currencies ? Accepting currencies — cryptocurrencies and fiat currencies that can be used for buying the project tokens. :EOS, ETH,
    • Can't participate ? Can't participate — the countries where it is prohibited to buy tokens. These can be countries where ICOs are prohibited altogether, or countries that have the requirements that a particular project does not meet. :China, South Korea,
    • Know Your Customer (KYC) ? Know Your Customer — a verification procedure for ICO participants, during which the developers can ask for personal data, a photo and a scanned copy of a passport of a potential investor. :Yes
    Get details
  • Token and Funds Distribution

    Token distribution date


    Unsold tokens

      • Token Distribution

    Sale schedule

    Round Token Price Bonus Min / Max Purchase Soft Cap Hard Cap
    Public sale — Soon
    Start Soon
    0.11 USD No - Uncapped 120,000,000 IRYO
    Private pre-sale — Active
    28 May 12:00 UTC
    0.11 USD 20% - Uncapped 15,000,000 IRYO
    Public pre-sale — Ended
    28 Apr 00:00 UTC
    04 Apr 00:00 UTC
    0.11 USD 30% - Uncapped 60,000,000 IRYO
    • Team

      • Vasja Bočko photo
        Vasja Bočko
      • Dominik Žnidar photo
        Dominik Žnidar
      • Peter Kuralt photo
        Peter Kuralt
        Head of Strategic Development
      • Domen Savič photo
        Domen Savič
      • Andrej Mihelič photo
        Andrej Mihelič
        UX/UI Designer
      • Tjaša Zajc photo
        Tjaša Zajc
        Business Development & Communications
      • Alberto Malave photo
        Alberto Malave
        Project Manager
      • Luka Perčič photo
        Luka Perčič
        Lead Blockchain Researcher
      • Črt Vavroš photo
        Črt Vavroš
        Blockchain Developer & Security Advisor
      • Nejc Škerjanc photo
        Nejc Škerjanc
        Blockchain Developer
      • Matevž Mihalič photo
        Matevž Mihalič
        Backend Developer
      • Mateusz Krasucki photo
        Mateusz Krasucki
        Backend Developer
      • Homero Rivas MD photo
        Homero Rivas MD
        Director of Innovative Surgery at Stanford University School of Medicine
      • Moka Lantum MD photo
        Moka Lantum MD
        Medical Entrepreneur
      • Tomaž Štolfa photo
        Tomaž Štolfa
        Tech Entrepreneur
    • Advisors

      • Andraž Logar
        CEO of 3fs
      • Maja Zadel
        Former CEO of the National Primary Care Center in Ljubljana.
      • Brian de Francesca
        CEO of Ver2
      • Mate Beštek
        Former State Secretary of the Slovenian Ministry of Health.
      • Lea Dias
        Strategy Consultant for Healthcare ICT & Automation


    • 2015
      Preliminary Research

      3fs executed preliminary research on establishing common interoperability between international medical systems.

    • 2016

      3fs provided initial capital and support to establish Iryo. The team began by validating several proof of concepts and pilot projects.

    • 2017

      The Iryo Network was introduced to the public in order to address common downfalls of inoperable medical systems.

    • 2018
      Iryo Public Release

      Official crowdsale of Iryo tokens. Production grade, fully scalable implementation for Iryo partnerships.

    • 2019
      Iryo Integration

      Integration of interoperable unified health records, zero-knowledge storage, and blockchain permissions.

    • 2020
      Network Expansion

      Iryo Network system support and adoption of value-added services. Design and execution of Iryo certified clinics.